Description: Mark Baum, Imprimis Pharmaceuticals CEO, explains how his company is able to make a Daraprim drug alternative more accessible to patients.
Source: CNNMoney.com – video report
Date: Feb 04, 2016
Questions for discussion:
- What is the basis for criticizing the pharmaceutical industry?
- Do you believe there will be greater legal and regulatory reaction to these revelations?
- How should investors respond to these events?
Leave a Reply